| 000 | 01659 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515010133.0 | ||
| 264 | 0 | _c20060608 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1046-6673 | ||
| 024 | 7 |
_a10.1681/ASN.2005080854 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernier, Virginie | |
| 245 | 0 | 0 |
_aPharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. _h[electronic resource] |
| 260 |
_bJournal of the American Society of Nephrology : JASN _cJan 2006 |
||
| 300 |
_a232-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntidiuretic Hormone Receptor Antagonists |
| 650 | 0 | 4 |
_aBenzazepines _xtherapeutic use |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChromosomes, Human, X |
| 650 | 0 | 4 |
_aDiabetes Insipidus, Nephrogenic _xdrug therapy |
| 650 | 0 | 4 | _aGenetic Linkage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPyrrolidines _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Vasopressin _xgenetics |
| 700 | 1 | _aMorello, Jean-Pierre | |
| 700 | 1 | _aZarruk, Alexandro | |
| 700 | 1 | _aDebrand, Nicolas | |
| 700 | 1 | _aSalahpour, Ali | |
| 700 | 1 | _aLonergan, Michèle | |
| 700 | 1 | _aArthus, Marie-Françoise | |
| 700 | 1 | _aLaperrière, André | |
| 700 | 1 | _aBrouard, Rémi | |
| 700 | 1 | _aBouvier, Michel | |
| 700 | 1 | _aBichet, Daniel G | |
| 773 | 0 |
_tJournal of the American Society of Nephrology : JASN _gvol. 17 _gno. 1 _gp. 232-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1681/ASN.2005080854 _zAvailable from publisher's website |
| 999 |
_c15941662 _d15941662 |
||